Clinical Trial Update: Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of a valsartan/amlodipine combination in adults with essential hypertension, evaluated in Phase 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Essential Hypertension | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-02-04